Bakul Pharma Private Limited – FDA Inspection, Sep 26, 2024

Record Details

This FDA Inspection record concerns Bakul Pharma Private Limited, with an inspection on September 26, 2024, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Bakul Pharma Private Limited
Inspection Date: September 26, 2024
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Brandy N. Lepage (FDA Associated Person)

View Company Profile

ID · e9471c75-340a-45b1-a31b-485c4700aab8

Inspection Facts

Inspection number: 1250166
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bakul Pharma Private Limited

FDA Inspection

Bakul Pharma Private LimitedSeptember 26, 2024

Bakul Pharma Private Limited – FDA Inspection, Sep 26, 2024

Record Details

This FDA Inspection record concerns Bakul Pharma Private Limited, with an inspection on September 26, 2024, issued by the Office of Inspections and Investigations, covering human drugs.